Biotech | FavStocks

This Week’s Watchlist 10/17/11

17 October 2011 – 6:00 am PST

Comments Off

Last Week’s Catalyst Calendar Summary 10/15/11

17 October 2011 – 6:00 am PST

Comments Off

$YMI YM Bio Poised for Run-Up into Key Data in December

14 October 2011 – 4:26 am PST

Comments Off

YM BioSciences (AMEX:YMI) is a small-cap biopharmaceutical company with three products currently in clinical development, including CYT387 (a small molecule dual inhibitor of the JAK1/JAK2 kinases), nimotuzumab (an EGFR-targeting monoclonal antibody), and CYT997 (a vascular disrupting agent or VDA).

New Trade for 10/12/11

14 October 2011 – 4:10 am PST

Comments Off

New Trade 10/11/11

14 October 2011 – 3:56 am PST

Comments Off

$BDSI Phase 3 Trial Disappoints, but Additional Catalysts Pending

14 October 2011 – 3:36 am PST

Comments Off

BioDelivery Sciences (NASDAQ:BDSI) is a specialty pharmaceutical company that is focused on the development of pain drugs utilized in supportive cancer care that represent novel formulations of marketed drugs utilizing BioErodible MucoAdhesive (BEMA) Film Technology, which is designed for the rapid absorption and delivery of drugs into the bloodstream from the inside of the mouth.